Medical Excellence Capital

Medical Excellence Capital

Nissequogue, New Yorkmedexcelcap.com

Overview

Medical Excellence Capital (MEC) is an early-stage venture capital firm focused on the life sciences and healthcare industry . MEC provides company creation, seed, and early-stage capital to innovators in precision medicine such as cell therapy, gene therapy, AI/ML applied to drug discovery, synthetic biology, and regenerative medicine . MEC invests solely in high-potential companies where its expertise, insights, and global network can promote acceleration and maximized value creation .

Year Founded

2020

Portfolio Companies

9

Investments

CompanyDateStageLead
Aspen NeuroscienceNov 2025Series CCo-investor
Ladder BioNov 2025SeedLead
PLENODec 2024Series BCo-investor
PlenoDec 2024Series BCo-investor
GCTxSep 2024Series A-

Key People

Brian Halak

Managing Partner

Eric Heil

Managing Partner

Joni Mancini

Managing Partner

Kim Kamdar

Managing Partner

Muhamad Furqon

Commercial Investment Partner Senior Partner, Audit And Risk Committee(semi-retired)

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNissequogue, New York
Year Founded2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.